Systemically Administered Low-Affinity HER2 CAR T Cells Mediate Antitumor Efficacy Without Toxicity
JOURNAL FOR IMMUNOTHERAPY OF CANCER(2024)
Key words
Tumor infiltrating lymphocyte - TIL,T cell,Relapse,Immune related adverse event - irAE,Adoptive cell therapy - ACT
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined